NFKB1 and neoplasm: Some of the AP1 target genes are also regulated by NFκB transcription factor [16], and inactivation of IKKβ - an activator of NFκB in intestinal epithelial cells - leads to dramatic reduction in tumor number after AOM/DSS treatment [41] due to increase in apoptosis.